FTSE 100 hits two-year high as GSK boosts


  • Markets
  • Tuesday, 18 Jan 2022

Unilever shares dropped 7.0% and were the worst performer on the index. A report said the company was in talks with banks for additional financing to make a potential sweetened offer.

LONDON: London's FTSE ended higher on Monday, aided by healthcare stocks as GlaxoSmithKline jumped after rejecting a 50-billion-pound buyout offer for its consumer arm from Unilever, while energy and mining stocks also provided support.

The blue-chip FTSE 100 index gained 0.9% to record its highest closing in nearly two years, with miner Glencore and energy majors BP and Royal Dutch Shell among the biggest boosts to the index.

GlaxoSmithKline jumped 4.1% after it said over the weekend that it had rejected Unilever's offer for its consumer goods arm and would stick to its plan of spinning off the unit.

Unilever shares dropped 7.0% and were the worst performer on the index. A report said the company was in talks with banks for additional financing to make a potential sweetened offer.

"Paying 50 billion pounds for a business that sells pain relief products and toothpastes comes across as a risky bet and while there appears to be universal consensus that Unilever needs to shake up its business... the price tag for doing so seems a little on the rich side," CMC Markets analyst Michael Hewson said.

Analysts at Barclays said that Unilever's offer and the ensuing valuations are very complex to execute in normal times, let alone in the middle of a global pandemic.

The domestically focussed mid-cap index rose 0.6%.

Homebuilders gained 1.0% after a survey showed asking prices for British homes rose by the most in annual terms in nearly six years in early 2022.

Taylor Wimpey Plc, the UK's third-largest housebuilder, added 4.2% after saying it expected annual results in line with its forecasts.

Meanwhile, Clinigen Group Plc dropped 0.8% after agreeing to a sweetened takeover offer by UK-based private equity firm Triton that valued the pharmaceutical services firm at about 1.3 billion pounds ($1.78 billion). = Reuters

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

FTSE 100 , two-year high , GSK , Uniliver ,

   

Next In Business News

ANALYSIS-Stock and bond divergence offers hope for battered 60/40 portfolio
Fed embraces 50-basis-point rate hikes in June, July to curb 'very high' inflation
World Bank's Malpass says war in Ukraine may trigger global recession
Oil edges higher on tight supply, rising US refining activity
Global shares rise after Fed meeting notes hint at future rate hikes
Higher food prices fuel concerns
ECB warns of corporate weakness amid slower growth
Matrix FY22 new property sales at all-time high
Foreign-exchange losses affect Axiata 1Q results
SDP on track to sustain profitability

Others Also Read